A detailed history of Dimensional Fund Advisors LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 16,201 shares of TMDX stock, worth $988,585. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,201
Holding current value
$988,585
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$135.68 - $176.11 $2.2 Million - $2.85 Million
16,201 New
16,201 $2.54 Million
Q3 2023

Nov 09, 2023

SELL
$53.47 - $96.07 $9.17 Million - $16.5 Million
-171,473 Reduced 69.78%
74,277 $4.07 Million
Q2 2023

Aug 09, 2023

SELL
$66.23 - $88.73 $122,393 - $163,973
-1,848 Reduced 0.75%
245,750 $20.6 Million
Q1 2023

May 12, 2023

SELL
$53.63 - $82.33 $281,932 - $432,808
-5,257 Reduced 2.08%
247,598 $18.8 Million
Q4 2022

Feb 09, 2023

SELL
$39.08 - $64.29 $51,898 - $85,377
-1,328 Reduced 0.52%
252,855 $15.6 Million
Q3 2022

Nov 10, 2022

SELL
$31.56 - $55.75 $38,818 - $68,572
-1,230 Reduced 0.48%
254,183 $10.6 Million
Q2 2022

Aug 12, 2022

SELL
$20.56 - $32.15 $1.03 Million - $1.61 Million
-50,140 Reduced 16.41%
255,413 $8.03 Million
Q1 2022

May 13, 2022

SELL
$12.58 - $26.94 $679,269 - $1.45 Million
-53,996 Reduced 15.02%
305,553 $8.23 Million
Q4 2021

Feb 09, 2022

SELL
$19.16 - $32.68 $327,885 - $559,252
-17,113 Reduced 4.54%
359,549 $6.89 Million
Q3 2021

Nov 12, 2021

SELL
$25.92 - $34.51 $505,958 - $673,635
-19,520 Reduced 4.93%
376,662 $12.5 Million
Q2 2021

Aug 12, 2021

BUY
$21.63 - $40.07 $5.38 Million - $9.96 Million
248,513 Added 168.29%
396,182 $13.1 Million
Q1 2021

May 14, 2021

BUY
$17.75 - $47.82 $2.23 Million - $6.02 Million
125,823 Added 575.95%
147,669 $6.13 Million
Q4 2020

Feb 25, 2021

BUY
$11.91 - $19.9 $260,185 - $434,735
21,846 New
21,846 $435,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.94B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.